Artificial Pulmonary Valve System Industry Research Report 2025

Summary

According to APO Research, the global Artificial Pulmonary Valve System market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Artificial Pulmonary Valve System is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Artificial Pulmonary Valve System is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Artificial Pulmonary Valve System is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Artificial Pulmonary Valve System include Edwards Lifesciences, Epicor Medical, Terumo, Valtech Cardio, Boston Scientific, Venus Medtech Medical Device, Medtronic and Abbott, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Artificial Pulmonary Valve System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Pulmonary Valve System.

The report will help the Artificial Pulmonary Valve System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Artificial Pulmonary Valve System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Pulmonary Valve System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Artificial Pulmonary Valve System Segment by Company

Edwards Lifesciences
Epicor Medical
Terumo
Valtech Cardio
Boston Scientific
Venus Medtech Medical Device
Medtronic
Abbott
Artificial Pulmonary Valve System Segment by Type

PLA
PCL
Others
Artificial Pulmonary Valve System Segment by Application

Pulmonary Valve Regurgitation
Pulmonary Valve Stenosis
Pulmonary Hypertension
Others
Artificial Pulmonary Valve System Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers


High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Pulmonary Valve System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Pulmonary Valve System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Pulmonary Valve System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Artificial Pulmonary Valve System manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Artificial Pulmonary Valve System by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Artificial Pulmonary Valve System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Artificial Pulmonary Valve System Market Size (2020-2031)
2.2.2 Global Artificial Pulmonary Valve System Sales (2020-2031)
2.2.3 Global Artificial Pulmonary Valve System Market Average Price (2020-2031)
2.3 Artificial Pulmonary Valve System by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 PLA
2.3.3 PCL
2.3.4 Others
2.4 Artificial Pulmonary Valve System by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Pulmonary Valve Regurgitation
2.4.3 Pulmonary Valve Stenosis
2.4.4 Pulmonary Hypertension
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Artificial Pulmonary Valve System Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Artificial Pulmonary Valve System Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Artificial Pulmonary Valve System Revenue of Manufacturers (2020-2025)
3.4 Global Artificial Pulmonary Valve System Average Price by Manufacturers (2020-2025)
3.5 Global Artificial Pulmonary Valve System Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Artificial Pulmonary Valve System, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Artificial Pulmonary Valve System, Product Type & Application
3.8 Global Manufacturers of Artificial Pulmonary Valve System, Established Date
3.9 Global Artificial Pulmonary Valve System Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Edwards Lifesciences
4.1.1 Edwards Lifesciences Company Information
4.1.2 Edwards Lifesciences Business Overview
4.1.3 Edwards Lifesciences Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Edwards Lifesciences Artificial Pulmonary Valve System Product Portfolio
4.1.5 Edwards Lifesciences Recent Developments
4.2 Epicor Medical
4.2.1 Epicor Medical Company Information
4.2.2 Epicor Medical Business Overview
4.2.3 Epicor Medical Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Epicor Medical Artificial Pulmonary Valve System Product Portfolio
4.2.5 Epicor Medical Recent Developments
4.3 Terumo
4.3.1 Terumo Company Information
4.3.2 Terumo Business Overview
4.3.3 Terumo Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Terumo Artificial Pulmonary Valve System Product Portfolio
4.3.5 Terumo Recent Developments
4.4 Valtech Cardio
4.4.1 Valtech Cardio Company Information
4.4.2 Valtech Cardio Business Overview
4.4.3 Valtech Cardio Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Valtech Cardio Artificial Pulmonary Valve System Product Portfolio
4.4.5 Valtech Cardio Recent Developments
4.5 Boston Scientific
4.5.1 Boston Scientific Company Information
4.5.2 Boston Scientific Business Overview
4.5.3 Boston Scientific Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Boston Scientific Artificial Pulmonary Valve System Product Portfolio
4.5.5 Boston Scientific Recent Developments
4.6 Venus Medtech Medical Device
4.6.1 Venus Medtech Medical Device Company Information
4.6.2 Venus Medtech Medical Device Business Overview
4.6.3 Venus Medtech Medical Device Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Venus Medtech Medical Device Artificial Pulmonary Valve System Product Portfolio
4.6.5 Venus Medtech Medical Device Recent Developments
4.7 Medtronic
4.7.1 Medtronic Company Information
4.7.2 Medtronic Business Overview
4.7.3 Medtronic Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Medtronic Artificial Pulmonary Valve System Product Portfolio
4.7.5 Medtronic Recent Developments
4.8 Abbott
4.8.1 Abbott Company Information
4.8.2 Abbott Business Overview
4.8.3 Abbott Artificial Pulmonary Valve System Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Abbott Artificial Pulmonary Valve System Product Portfolio
4.8.5 Abbott Recent Developments
5 Global Artificial Pulmonary Valve System Market Scenario by Region
5.1 Global Artificial Pulmonary Valve System Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Artificial Pulmonary Valve System Sales by Region: 2020-2031
5.2.1 Global Artificial Pulmonary Valve System Sales by Region: 2020-2025
5.2.2 Global Artificial Pulmonary Valve System Sales by Region: 2026-2031
5.3 Global Artificial Pulmonary Valve System Revenue by Region: 2020-2031
5.3.1 Global Artificial Pulmonary Valve System Revenue by Region: 2020-2025
5.3.2 Global Artificial Pulmonary Valve System Revenue by Region: 2026-2031
5.4 North America Artificial Pulmonary Valve System Market Facts & Figures by Country
5.4.1 North America Artificial Pulmonary Valve System Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Artificial Pulmonary Valve System Sales by Country (2020-2031)
5.4.3 North America Artificial Pulmonary Valve System Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Artificial Pulmonary Valve System Market Facts & Figures by Country
5.5.1 Europe Artificial Pulmonary Valve System Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Artificial Pulmonary Valve System Sales by Country (2020-2031)
5.5.3 Europe Artificial Pulmonary Valve System Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Artificial Pulmonary Valve System Market Facts & Figures by Country
5.6.1 Asia Pacific Artificial Pulmonary Valve System Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Artificial Pulmonary Valve System Sales by Country (2020-2031)
5.6.3 Asia Pacific Artificial Pulmonary Valve System Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Artificial Pulmonary Valve System Market Facts & Figures by Country
5.7.1 South America Artificial Pulmonary Valve System Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Artificial Pulmonary Valve System Sales by Country (2020-2031)
5.7.3 South America Artificial Pulmonary Valve System Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Artificial Pulmonary Valve System Market Facts & Figures by Country
5.8.1 Middle East and Africa Artificial Pulmonary Valve System Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Artificial Pulmonary Valve System Sales by Country (2020-2031)
5.8.3 Middle East and Africa Artificial Pulmonary Valve System Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Artificial Pulmonary Valve System Sales by Type (2020-2031)
6.1.1 Global Artificial Pulmonary Valve System Sales by Type (2020-2031) & (K Units)
6.1.2 Global Artificial Pulmonary Valve System Sales Market Share by Type (2020-2031)
6.2 Global Artificial Pulmonary Valve System Revenue by Type (2020-2031)
6.2.1 Global Artificial Pulmonary Valve System Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Artificial Pulmonary Valve System Revenue Market Share by Type (2020-2031)
6.3 Global Artificial Pulmonary Valve System Price by Type (2020-2031)
7 Segment by Application
7.1 Global Artificial Pulmonary Valve System Sales by Application (2020-2031)
7.1.1 Global Artificial Pulmonary Valve System Sales by Application (2020-2031) & (K Units)
7.1.2 Global Artificial Pulmonary Valve System Sales Market Share by Application (2020-2031)
7.2 Global Artificial Pulmonary Valve System Revenue by Application (2020-2031)
7.2.1 Global Artificial Pulmonary Valve System Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Artificial Pulmonary Valve System Revenue Market Share by Application (2020-2031)
7.3 Global Artificial Pulmonary Valve System Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Artificial Pulmonary Valve System Value Chain Analysis
8.1.1 Artificial Pulmonary Valve System Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Artificial Pulmonary Valve System Production Mode & Process
8.2 Artificial Pulmonary Valve System Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Artificial Pulmonary Valve System Distributors
8.2.3 Artificial Pulmonary Valve System Customers
9 Global Artificial Pulmonary Valve System Analyzing Market Dynamics
9.1 Artificial Pulmonary Valve System Industry Trends
9.2 Artificial Pulmonary Valve System Industry Drivers
9.3 Artificial Pulmonary Valve System Industry Opportunities and Challenges
9.4 Artificial Pulmonary Valve System Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings